Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,204,000 | 1,326,000 | 818,492 | 996,156 | 633,695 |
| Depreciation Amortization | 71,000 | 60,000 | 42,834 | 51,259 | 39,457 |
| Accounts receivable | -166,000 | -230,000 | 115,724 | -313,361 | -170,873 |
| Other Working Capital | 225,000 | -109,000 | 197,762 | -273,288 | -122,507 |
| Other Operating Activity | -148,000 | 79,000 | -103,237 | 93,173 | -25,297 |
| Operating Cash Flow | $1,186,000 | $1,126,000 | $1,071,576 | $553,939 | $354,475 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,631,000 | 388,000 | -127,050 | -340,548 | -166,260 |
| PPE Investments | -7,215,000 | N/A | 0 | 0 | 0 |
| Net Acquisitions | N/A | -1,783,000 | N/A | N/A | N/A |
| Purchase Of Investment | -4,000 | -8,000 | -4,501 | -5,522 | -16,228 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 69,686 |
| Purchase Sale Intangibles | -55,000 | -44,000 | -54,595 | -44,887 | -40,093 |
| Other Investing Activity | -55,000 | -44,000 | -54,595 | -44,887 | -40,093 |
| Investing Cash Flow | $-5,643,000 | $-1,447,000 | $-186,146 | $-390,958 | $-152,895 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,500,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 23,000 | 19,000 | 22,070 | 39,648 | 21,479 |
| Common Stock Repurchased | -430,000 | -560,000 | -81,893 | -128,573 | -71,118 |
| Other Financing Activity | -304,000 | -25,000 | -28,169 | -22,798 | -17,183 |
| Financing Cash Flow | $4,789,000 | $-566,000 | $-87,991 | $-111,722 | $-66,822 |
| Exchange Rate Effect | 3,000 | 63,000 | -75,214 | 81,278 | 135,235 |
| Beginning Cash Position | 1,380,000 | 2,204,000 | 1,436,464 | 1,268,311 | 1,155,066 |
| End Cash Position | 1,715,000 | 1,380,000 | 2,158,688 | 1,400,849 | 1,425,059 |
| Net Cash Flow | $335,000 | $-824,000 | $722,225 | $132,538 | $269,993 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,186,000 | 1,126,000 | 1,071,576 | 553,939 | 354,475 |
| Capital Expenditure | -7,215,000 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -6,029,000 | 1,126,000 | 1,071,576 | 553,939 | 354,475 |